BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...
BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...
BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.
Becton Dickinson (BDX) announced full enrollment of the iliac artery patient cohort in its AGILITY investigational device ...
News-Medical.Net on MSN
Sirolimus-eluting balloon emerges as a safe and effective option for coronary in-stent restenosis
A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis ...
One question, in light of FREEDOM, is how well new DES compare with CABG in patients with diabetes and multivessel disease.
MedPage Today on MSN
RDN's Coverage Decision; Intracoronary Stem Cell Tx; Crab-Walk Technique for M-TEER
CMS issued a final National Coverage Determination (NCD) that green-lights renal denervation (RDN) for uncontrolled ...
Greater Kashmir on MSN
Next-Generation Ultrathin stents found safe, effective in diabetic patients with Multivessel Coronary Artery Disease: Study
Researchers said the low rates of restenosis, stent thrombosis, and myocardial infarction demonstrate the significant impact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback